In Brief: National Medical Care grand jury probe
This article was originally published in The Gray Sheet
Executive SummaryNational Medical Care grand jury probe: U.S. Attorney General for the District of New Jersey will not pursue prosecution of possible criminal law violations regarding National Medical Care's efforts to convince FDA to lift a 1991 import ban of dialysis devices from the firm's Dublin, Ireland facility, the W.R. Grace unit announces. In February, the company received word that the New Jersey grand jury, which continues to investigate NMC's sale of allegedly defective products and handling of customer complaints, was considering action against NMC for violating federal rules prohibiting firms from making false submissions to the government ("The Gray Sheet" Feb. 19, I&W-14). The firm also is the target of a Virginia grand jury involving contractual relationships between NMC subsidiaries and service providers and an HHS probe regarding possible reimbursement violations...
You may also be interested in...
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.